$117.17
-0.06-0.05%
At Close: -
$117.26
0.090.07%
After Hours: 5:53 PM EDT
15 minutes delayed
Merck & Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Merck & Co using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $2.28 | $2.15 | 6.05 % |
Mar 2024 | 2024-04-25 | $2.07 | $1.87 | 10.7 % |
Dec 2023 | 2024-02-01 | $0.03 | $-0.11 | 127.3 % |
Sep 2023 | 2023-10-26 | $2.13 | $1.95 | 9.23 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-30 | $16.11B | $15.84B | 1.72 % |
Mar 2024 | 2024-04-25 | $15.78B | $15.20B | 3.78 % |
Dec 2023 | 2024-02-01 | $14.63B | $14.50B | 0.91 % |
Sep 2023 | 2023-10-26 | $15.96B | $15.32B | 4.19 % |
Merck & Co (MRK) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on July 30, 2024 for Q2.
The Actual EPS was $2.28, which beat the estimate of $2.15.
The Actual Revenue was $16.1B, which beat the estimate of $15.8B.
Browse earnings estimates, EPS, and revenue on all stocks.